Wenjun Liang Selected Research

Epitopes

1/2019

Structural mapping of hot spots within human CASPR2 discoidin domain for autoantibody recognition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenjun Liang Research Topics

Disease

4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 05/2015
3	Neoplasms (Cancer) 03/2020 - 04/2015
2	Lung Neoplasms (Lung Cancer) 10/2020 - 09/2016
2	Breast Neoplasms (Breast Cancer) 03/2020 - 04/2015
1	Ischemic Stroke 04/2022
1	Adenocarcinoma of Lung 03/2020
1	Immune System Diseases (Immune Disorders) 01/2019
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017
1	Neoplasm Metastasis (Metastasis) 05/2015
1	Carcinogenesis 05/2015
1	Lymphatic Metastasis 05/2015
1	Prostatic Neoplasms (Prostate Cancer) 04/2015
1	Colonic Neoplasms (Colon Cancer) 04/2015
1	Tuberculosis (Tuberculoses) 01/2015

Drug/Important Bio-Agent (IBA)

2	Long Noncoding RNAIBA 10/2020 - 09/2016
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Ribonuclease P (RNase P)IBA 10/2020
1	Actins (F Actin)IBA 10/2020
1	Dynamins (Dynamin)IBA 10/2020
1	Protein Kinase CIBA 03/2020
1	Alanine (L-Alanine)FDA Link 03/2020
1	Biological ProductsIBA 03/2020
1	anti-CASPR2 autoantibodyIBA 01/2019
1	EpitopesIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 09/2017
1	Biomarkers (Surrogate Marker)IBA 09/2016
1	growth arrest specific transcript 5IBA 09/2016
1	Cadherins (E-Cadherin)IBA 05/2015
1	DecorinIBA 05/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 04/2015
1	Vitamin D FDA LinkGeneric 01/2015

Therapy/Procedure

1	Chiropractic Manipulation 04/2022
1	Therapeutics 09/2017